block

2,5-Furandicarboxylic acid (Dehydromucic Acid) is a normal urinary metabolite in humans. 2,5-Furandicarboxylic acid is also a microbial metabolite, a product of the oxidation of hydroxymethylfurfural (HMF) by the enzyme furfural/HMF oxidoreductase which is found in the bacterium Cupriavidus basilensis.

Block polyoxyethylene-polyoxypropylene is a block copolymer composed of hydrophilic polyoxyethylene (POE) and hydrophobic polyoxypropylene (POP). It is utilized in the formulation of emulsifiers, drug delivery vehicles, and stabilizers in various biomaterials.

Poly(styrene)-block-poly(acrylic acid) (PS:PAA 30000:2000) is a diblock copolymer utilized for creating polymer micelles, vesicles, and in various encapsulation applications.

Poly(styrene)-block-poly(acrylic acid) (PS:PAA 3,000:5,000, DDMAT terminated) is a diblock copolymer used for producing polymer micelles, vesicles, and various encapsulation applications.

IEM 1754 2HBr (IEM 1754 dihydrobromide) is a selective AMPA/kainate receptor blockers for GluR1 and GluR3 with IC₅₀ of 6 μM.

Pheniramine maleate (Trimetose), an alkylamine derivative with antihistaminic and vasodilatory properties, binds to histamine H1 receptors, thereby inhibiting phospholipase A2 and production of the endothelium-derived relaxing factor, nitric oxide.

Sugammadex sodium (Org25969) , a synthetic derivative of γ-cyclodextrin, is a steroid-based neuromuscular blocker reversing agent.

BLT-1 is a scavenger receptor BI (SR-BI)inhibitor.

DMT1 blocker 1 is a blocker of divalent metal transporter 1 (DMT1) with IC₅₀ of 0.64 μM, which is expected to block the absorption of iron by intestinal cells in vivo.

(+)-KCC2 blocker 1 is a selective inhibitor of KCC2 with an IC₅₀ of 0.4 μM.

TRPV2-selective blocker 1 is a selective TRPV2 channel blocker with an IC₅₀ of 6.3 μM. It has no effect on TRPV1/3/4, and inhibits TRPV2-mediated Ca²⁺ influx and phagocytosis in macrophages.

Rhodblock 6 is a Rho kinase (ROCK) inhibitor that specifically inhibits Rho kinase activity and the localization of phosphorylated MRLC (Myosin Regulatory Light Chain).

MitoBloCK-11 (MB-11) is a s mall molecule inhibitor of mitochondrial protein import possibly acts through transport protein Seo1, but not Tom70 or Tom20; inhibits precursor proteins that contain hydrophobic segments, confers growth in media lacking uracil in a specific manner and affects zebrafish development.

DMT1 blocker 2, compound 12f, is a direct inhibitor of divalent metal transporter 1 (DMT1) with an IC₅₀ hydrogen peroxide value of 0.83, which is expected to block iron uptake by intestinal epithelial cells in vivo.

N-type calcium channel blocker-1 is an orally active analgesic agent with a high affinity for functionally blocking N-type calcium channels.

NMDAR blocker 1 is an NMDA receptor channel blocker with an IC₅₀ of 5.0 μM. It features rapid switching block kinetics and strong voltage dependency, without competing for glutamate or glycine binding sites. This compound can prevent intracellular Ca2+ overload induced by glutamate/NMDA and modulates the glutamate-nitric oxide-cGMP pathway. In vitro, NMDAR blocker 1 inhibits excitotoxic neurodegeneration in cultured cerebellar and hippocampal neurons. Additionally, it reduces excitotoxic damage in a mouse model of hyperammonemia-induced excitotoxicity, making it applicable for research into neurodegenerative diseases.

Cav 2.2 blocker 1 is an N-type calcium channel (Cav 2.2; IC₅₀: 1 nM) blocker for the treatment of pain.

M2 ion channel blocker ,Antiviral agent, is capable of inhibiting and blocking the activity of M2 ion channel.

MTDH-SND1 blocker 2 (compound C19) is an effective MTDH-SND1 inhibitor with an IC₅₀ value of 487 nM. It binds to the SND1 protein with a Kd of 279 nM and can degrade the SND1 protein. Additionally, MTDH-SND1 blocker 2 exhibits antiproliferative activity and induces apoptosis, showing potential for breast cancer research.

Cav 3.1 blocker 1 (compound 12) is a T-type calcium channel inhibitor with an IC₅₀ value of 160 nM for Cav3.1. It exhibits weaker inhibition on Cav 3.2 with an IC₅₀ of 5000 nM and shows no inhibitory effect on Cav 3.3 and Cav 1.2 (IC₅₀ > 10000 nM).

Rhodblock 1a is an inhibitor of the Rho kinase signaling pathway, which disrupts the localization and function of proteins within the Rho pathway. This interference hinders the proper formation of the cleavage furrow during cell division, leading to some cells either failing to form the cleavage furrow or forming a ruptured furrow, resulting in binucleated cells. Rhodblock 1a can be utilized for investigating cell division mechanisms and holds potential for research into cardiovascular diseases and cancer.

FAAH/TRPV1 blocker-1 (compound 2R) is a dual blocker of FAAH and TRPV1, exhibiting IC₅₀ values of 0.12 μM and 94.9 μM, respectively. This compound plays a significant role in research focused on pain relief and anti-inflammatory effects.

M2 ion channel blocker-2 (Compound 10) is an inhibitor of the M2 ion channel. It effectively blocks both the wild type and mutant M2 (L27F and V27A) ion channels. This compound exhibits potent antiviral activity against HCoV-229E, with an EC50 of 4.7 μM for cytopathic effect, but shows no efficacy against influenza A virus. Additionally, M2 ion channel blocker-2 does not significantly inhibit hERG or cytochrome P450 enzymes (CYP1A2, CYP2C19, and CYP3A4).

MitoBloCK-1 is an inhibitor that obstructs the import of substrates reliant on the TIM22 pathway. It acts by preventing substrates from binding to the tim9/10 complex, thereby inhibiting their transport and preventing them from reaching the TIM22 translocase. MitoBloCK-1 impedes the mitochondrial import of TIM22 substrate proteins. Additionally, it hampers the transport of carrier proteins, such as ADP/ATP and phosphate carriers, and also inhibits the translocation of another carrier protein, PiC, along with the outer membrane protein Tom40.